                               SEQUENCE LISTING	

<110> UNIVERSITY OF TOLEDO
 
<120> SOLUBLE GUANYLYL CYCLASE ALPHA1 AND A-8R PEPTIDE AS DIAGNOSTIC 
      MARKERS OF AND THERAPEUTIC TARGETS FOR PROSTATE CANCER

<130> 53-50574

<140>
<141>

<150> 61/182,712
<151> 2009-05-30

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Thr Phe Cys Lys Ala Phe Pro Phe His Ile Ile Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg Arg 
            


<210> 2
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Leu Arg Leu Lys Gly Gln Met Ile Tyr Leu Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg 
        


<210> 3
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Pro Leu His Asp Ala Thr Arg Asp Leu Val Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg 
        


<210> 4
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Arg Ala Leu Glu Asp Glu Lys Lys Lys Thr Asp Thr Leu Leu Tyr Ser 
1               5                   10                  15      


Val Leu Pro Pro Arg Arg Arg Arg Arg Arg Arg Arg 
            20                  25              


<210> 5
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Thr Phe Cys Lys Ala Phe Pro Phe His Ile Ile 
1               5                   10      


<210> 6
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Arg Arg Arg Arg Arg Arg Arg Arg 
1               5              



